Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Bayridge Resources Corporation C.BYRG

Alternate Symbol(s):  BYRRF

Metals & Mining Industrial Metals & Minerals
Bayridge Resources Corp. engages in the acquisition, exploration, and development of mineral properties in Canada. The company primarily explores for uranium. Its flagship property is the Waterbury East property that includes 1 mineral claim covering an area of 1,337 hectares located in the northeastern Athabasca Basin. The company was formerly known as Aspen Resources Corp. and changed its... see more

Current News (CSE:BYRG)

Bayridge Resources Signs Definitive Agreement on Baker Lake Uranium Project in Nunavut

Newsfile November 24, 2025

CSE Bulletin: MOC Eligibility Update

Newsfile November 10, 2025

Bayridge Announces Cancellation of Stock Options

Newsfile October 7, 2025

Bayridge Announces Acquisition of 40% Interest in Waterbury East Property

Newsfile October 1, 2025

CSE Bulletin: Consolidation - Bayridge Resources Corp. (BYRG)

Newsfile August 28, 2025

Bayridge Announces Record Date for Share Consolidation

Newsfile August 25, 2025

Bayridge Announces Proposed Share Consolidation

Newsfile August 13, 2025

Bayridge Resources Announces Commencement of Its Maiden Drill Program at the Constellation Project

Newsfile July 21, 2025

Bayridge Resources Corp. Reports Voting Results from Annual General and Special Meeting

Newsfile June 27, 2025
View More News ››

Opinion & Analysis (CSE:BYRG)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:BYRG)

Bayridge is going deep at Constellation...

BYRG is officially boots-on-the-ground at its Constellation uranium project. The company’s first-ever drill program is now underway...
zack50 - August 10, 2025

Drill crews mobilized...

Bayridge is gearing up to drill its first-ever holes at the Constellation uranium project. They’re kicking off a 1,000m...
zack50 - July 21, 2025

BYRG confirms multiple targets at Constellation Project...

Highlights: Grab sample of 28.1 ppm uranium located 750m SE of historic SMDI occurrence, and along strike with a large...
zack50 - February 5, 2025

Bayridge Resources Drilling Update at Waterbury East Project

The fall 2024 drilling program at Bayridge's 1,337 ha Waterbury East uranium project in Canada's Athabasca Basin has been...
zack50 - November 20, 2024

Drilling Update at Waterbury East Project... 10/16/24

  Bayridge Resources has completed the first two holes of its fall 2024 drilling program at its 1,337 ha Waterbury East...
zack50 - October 16, 2024

Drilling has commenced...

Bayridge Resources Corp. (CSE: BYRG) has commenced its fall 2024 drilling program at its 1,337 ha Waterbury East uranium project in...
zack50 - October 2, 2024
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms ...
View More »